RAP-219 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Bipolar 1 Disorder
Rapport Therapeutics Inc.224 enrolled22 locationsNCT07046494
Recruiting
Phase 2
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
EpilepsyRefractory Focal EpilepsyFocal Epilepsy
Rapport Therapeutics Inc.30 enrolled7 locationsNCT07219407